A study was published in the February issue of Otology and Neurotology on the affects of aspirin with relation to vestibular schwannomas. It was done by researchers from Massachusetts Eye and Ear, Harvard Medical School, Massachusetts Institute of Technology and Massachusetts General Hospital and conducted at the Molecular Neurotology Laboratory at Mass. Eye and Ear.
Analysis was done on 600 patients who were diagnosed with vestibular schwannomas. Out of the retrospective 689 people, 505 of the patients had multiple MRI. There was a significant relation between patients who used aspirin and vestibular schwannoma growth. An odds ratio of 0.50, or 95% and confidence interval of 0.29-0.85 was observed. This was irrespective of any age or gender. The inherent potential of aspirin as a therapeutic medicine in restricting the tumour growth cannot be done away with. More studies in this regard are needed to understand the overall efficacy of this drug to stop or restrict such growths.
No comments:
Post a Comment